Events2Join

Drug Interactions Among HIV Patients Receiving Concurrent ...


Drug Interactions Among HIV Patients Receiving Concurrent ...

This article will assess the interactions between antiretroviral agents (Table 1) and neuropathic pain medications (both approved and off-label; Table 2)

Drug Interactions and Antiretroviral Drug Monitoring - PMC

Based on the various observed interactions between immunosuppressive and antiretroviral drugs, HIV-infected patients who undergo organ ...

Drug Interactions Among HIV Patients Receiving Concurrent ...

The interactions between antiretroviral agents and neuropathic pain medications (both approved and off-label; Table 2) are assessed, with the aim of ...

Core Concepts - Drug Interactions with Antiretroviral Medications

The most commonly encountered drug interactions in the context of HIV clinical care occur between antiretroviral therapies and medications used to manage common ...

Resource: ART Drug-Drug Interactions - Clinical Guidelines Program

The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients. Clin Pharmacol Ther 2008;83(2):265-72. [PMID ...

Drug–Drug Interactions with HIV Antiretroviral Therapy

Therefore, in patients receiving carbamazepine concurrently with a ritonavir-containing HAART regimen, careful monitoring of carbamazepine ...

Drug-Drug Interactions between Antiretrovirals and Other Drugs | NIH

Pharmacokinetic (PK) drug–drug interactions between antiretroviral (ARV) drugs and concomitant medications are common and may lead to increased or decreased ...

Concurrent use of drugs and potential drug interactions in HIV ...

among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications. Int J Risk Saf Med 2017; 29(1-2):25-55. 5 ...

Full article: Drug–drug interactions in HIV-infected patients receiving ...

Coadministration of antiretrovirals and anti-cancer medications may present many complex clinical scenarios. This is characterized by the potential for drug– ...

Potential drug–drug interactions due to concomitant medicine use ...

Concomitant medicine use is high among PLWH in Australia on antiretroviral therapy and a high proportion of people receive medicines that ...

Profile of drug–drug interactions and impact on the effectiveness of ...

No relationship was found between the number of drug–drug interactions and the effectiveness of antiretrovirals. As expected, the higher the number of non-HIV ...

Risk factors and impact on indicators of health-related quality of life

Introduction: While studies have extensively examined the clinical and pharmacokinetic correlates of drug-drug interactions (DDIs) with antiretroviral therapy ( ...

Relationship Between Polypharmacy and Quality of Life Among ...

Of all participants, 82.0% reported taking at least one non-HIV pill per day or taking medication currently for at least one non-HIV condition, ...

Managing drug interactions in HIV-infected adults with comorbid ...

The majority of antiretroviral drug interactions involve CYP3A4, but agents metabolized through other CYP450 isoenzymes, including CYP2B6, ...

clinically significant drug interactions among hiv-infected patients ...

We conducted a cross sectional study of the outpatient medical records of 1,000 HIV-infected patients receiving antiretroviral therapy (ART) in 2011 to.

The Challenge of Potential Drug–Drug Interactions Among People ...

Thus, the potential onset of DDIs becomes an essential concern for HIV-infected individuals with comorbidities that require concomitant ...

Pharmacokinetic interactions of modern antiretroviral therapy - AIDS

Drug--drug interactions (DDIs) have been a clinical challenge in HIV medicine for over two decades. The newer antiretroviral drugs (ARTs) have ...

Prevalence and nature of potential drug-drug interactions among ...

Management of co-infections including cryptococcal meningitis, tuberculosis and other opportunistic infections in persons living with HIV ...

Special Populations: Substance Use Disorders and HIV | NIH

Substance use may increase the likelihood of HIV transmission risk behaviors, the potential for drug–drug interactions, and the risk or severity of substance- ...

Drug–Drug Interactions Based on Pharmacogenetic Profile between ...

However, the concomitant use of HAART and AC can result in drug accumulation or possible toxicity with consequent decreased efficacy of one or both classes of ...